This week’s blog post features audio commentary from our head of RBC Biotechnology Research Dr. Kennen Mackay. Dr. MacKay updates us on COVID-19; he discusses the data on the number of cases and how close we are to a vaccine. He also provides information on the impact of the race to find effective treatments and answers the question on all of our minds: “When will we be back to normal?”